Thierry Petit

A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer

Pierre Farmer, Hervé Bonnefoi, Pascale Anderle et al. · Nature Medicine · 2009 · 616 citations · Full text

Medicine, Molecular Biology, Oncology +16

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

Thierry Petit, M. Wilt, Michel Velten et al. · European Journal of Cancer · 2003 · 273 citations

Medicine, Oncology, Pharmacology +17

RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

Hervé Bonnefoi, Anil Potti, Mauro Delorenzi et al. · The Lancet Oncology · 2007 · 218 citations · Full text

Medicine, Bioinformatics, Oncology +17

Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016

Élise Deluche, Alison Antoine, Thomas Bachelot et al. · European Journal of Cancer · 2020 · 192 citations

Medicine, Gynecology, Oncology +17

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

Xavier Pivot, Joseph Gligorov, Volkmar Müller et al. · Annals of Oncology · 2014 · 176 citations · Full text

Medicine, Oncology, Pharmacotherapy +15